Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/WA/Vancouver
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Vancouver, WA

Studies commonly pay $75 to $4,500 per completed study

1,016 clinical trials are currently recruiting participants within 30 miles of Vancouver. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

1,016studies recruiting
9+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Vancouver right now

Top 25 of 1,016 recruiting studies, sorted by proximity — each links to its official registry page

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Lymphoma, Non-Hodgkin, Multiple Myeloma Phase 2 Interventional 4,200 participants sought
Providence Health & Services — Portland, Oregon (8.7 mi) · Sponsor: American Society of Clinical Oncology
See eligibility & contact on ClinicalTrials.gov (NCT02693535)

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma Phase 2 Interventional 81 participants sought
Providence Portland Medical Center — Portland, Oregon (8.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05112601)

Immuno-PRISM (PRecision Intervention Smoldering Myeloma)

High-risk Smoldering Multiple Myeloma, Smoldering Multiple Myeloma Phase 2 Interventional 52 participants sought
Oregon Health & Science University — Portland, Oregon (8.7 mi) · Sponsor: Irene Ghobrial, MD
See eligibility & contact on ClinicalTrials.gov (NCT05469893)

Support Via Technology: Living and Learning With Advancing Dementia-REVISED

Caregiver Burden N/A Interventional 238 participants sought
Oregon Health & Science University, Layton Aging and Alzheimer's Disease Research Center — Portland, Oregon (8.7 mi) · Sponsor: Oregon Health and Science University
See eligibility & contact on ClinicalTrials.gov (NCT06460012)

A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer Phase 2 Interventional 120 participants sought
Providence Portland Medical Center — Portland, Oregon (8.7 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06465329)

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Lymphoma, Large B-Cell, Diffuse Phase 2 Interventional 594 participants sought
Northwest Cancer Specialists (Compass Oncology) ( Site 8000) — Vancouver, Washington (3.1 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06890884)

Waveform Capnography Compared to Colorimetric Carbon Dioxide Detection During Tracheal Intubation of Critically Ill Adults

Acute Respiratory Failure N/A Observational 2,092 participants sought
Oregon Health and Sciences University — Portland, Oregon (8.7 mi) · Sponsor: Brian Driver
See eligibility & contact on ClinicalTrials.gov (NCT06934876)

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

PIK3CA Mutation, HER2- Negative Breast Cancer Phase 3 Interventional 540 participants sought
Oregon Health & Science University, Knight Cancer Institute — Portland, Oregon (8.7 mi) · Sponsor: Relay Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06982521)

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Carcinoma, Transitional Cell, Urinary Bladder Neoplasms Phase 3 Interventional 450 participants sought
Providence Portland Medical Center — Portland, Oregon (8.7 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07218380)

A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

Diabetic Macular Edema Phase 1, Phase 2 Interventional 49 participants sought
EyeHealth Northwest — Portland, Oregon (8.7 mi) · Sponsor: Boehringer Ingelheim
See eligibility & contact on ClinicalTrials.gov (NCT07553429)

OCT Angiography in Wet AMD

Neovascular (Wet) Age-related Macular Degeneration (AMD) N/A Observational 160 participants sought
Casey Eye Institute, Oregon Health & Science University — Portland, Oregon (8.7 mi) · Sponsor: Oregon Health and Science University
See eligibility & contact on ClinicalTrials.gov (NCT02253030)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
PeaceHealth Southwest Medical Center — Vancouver, Washington (3.1 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Large B-cell Lymphoma Phase 2 Interventional 250 participants sought
Oregon Health and Science University — Portland, Oregon (8.7 mi) · Sponsor: Allogene Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06500273)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University-Telemedicine — Portland, Oregon (8.7 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence

Prostate Cancer Phase 4 Interventional 142 participants sought
Oregon Health & Science University — Portland, Oregon (8.7 mi) · Sponsor: Blue Earth Diagnostics
See eligibility & contact on ClinicalTrials.gov (NCT07569926)

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease N/A Observational 3,000 participants sought
Oregon Clinic — Portland, Oregon (8.7 mi) · Sponsor: Duke University
See eligibility & contact on ClinicalTrials.gov (NCT01915511)

Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response

Chronic Low Back Pain N/A Interventional 2,529 participants sought
VA Portland Health Care System, Portland, OR — Portland, Oregon (8.7 mi) · Sponsor: VA Office of Research and Development
See eligibility & contact on ClinicalTrials.gov (NCT04142177)

Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function (VCSIP) Longer Term Follow Up

Asthma, Pulmonary Function N/A Observational 225 participants sought
Oregon Health and Science University (OHSU) — Portland, Oregon (8.7 mi) · Sponsor: Oregon Health and Science University
See eligibility & contact on ClinicalTrials.gov (NCT06106646)

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Non-Small Cell Lung Cancer Phase 3 Interventional 675 participants sought
Research Site — Vancouver, Washington (3.1 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06357533)

A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy

Heart Failure Phase 2 Interventional 200 participants sought
Providence St. Vincent Heart — Portland, Oregon (8.7 mi) · Sponsor: Novo Nordisk A/S
See eligibility & contact on ClinicalTrials.gov (NCT06979362)

Efficacy and Safety of 4F-PCC (4-Factor Prothrombin Complex Concentrate) in Adult Patients Undergoing Complex Cardiovascular Surgery With Cardiopulmonary Bypass (CPB)

Complex Cardiovascular Surgery With Cardiopulmonary Bypass Phase 3 Interventional 200 participants sought
Oregon Health & Sciences University — Portland, Oregon (8.7 mi) · Sponsor: CSL Behring
See eligibility & contact on ClinicalTrials.gov (NCT07094087)

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Urothelial Cancer, Bladder Cancer Phase 2, Phase 3 Interventional 630 participants sought
Research Site — Portland, Oregon (8.7 mi) · Sponsor: Daiichi Sankyo
See eligibility & contact on ClinicalTrials.gov (NCT07129993)
Actively enrolling

Studies you may be able to join near Vancouver

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Vancouver

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Oregon Medical Research Center

★ 4.4
1750 S Harbor Way Unit 330, Portland, OR 97201
(503) 245-1525
"Fantastic start to finish. The Staff at OMRC were kind, professional, helpful, informative, and were the first healthcare providers to believe me and…"
— Amy Pettinger, 5★

Legacy Research Institute

★ 4.4
1225 NE 2nd Ave, Portland, OR 97232
(503) 413-2491
"Safe place to get help, PES is a little uncomfortable but they get you a bed as fast as they can and the nurses are almost all nice"
— Lukas, 4★

Summit Research Network Oregon, Inc.

★ 4.6
2701 NW Vaughn St #350, Portland, OR 97210
(503) 279-8252
"The entire staff from the front dest to the lab lady's, doctors, and medical assistants are extremely compationate and friendly."
— Valerie Carter, 5★

Verity Health PNW

★ 5.0
3250 SE 164th Ave Ste 205, Vancouver, WA 98683
(360) 946-4313
"Knowledgeable, friendly, efficient"
— partlybohunk, 5★

Northwest Research Center

★ 5.0
6327 SE Milwaukie Ave, Portland, OR 97202
(503) 238-6233

Kaiser Permanente Center for Health Research

★ 3.4
3800 N Interstate Ave, Portland, OR 97227
(503) 335-2400
"So far, so good! Most professionals seems to be genuinely friendly."
— Luciano De Lopes, 5★

OHSU Mark O. Hatfield Research Center

★ 3.8
Hatfield Research Center, 3181 SW Sam Jackson Park Rd, Portland, OR 97239
"Doctors, surgeons, faculty, everyone is wonderful & top-of-their-game qualified."
— Robin Knauerhase, 5★

Providence Center for Outcomes Research and Education - Portland

★ 5.0
4400 NE Halsey St Bldg 1, Suite 265, Portland, OR 97213
(503) 215-7170

Advanced Research Institute-Portland

★ 5.0
13200 SW Pacific Hwy, Portland, OR 97223
(503) 610-0033
"My expriance is great all the time."
— chris Gonzalez, 5★

Clinical trials in Vancouver: what's recruiting

The Vancouver area currently has 1,016 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Vancouver, the most active research areas are:

  • Cancer & Oncology13 studies
  • Lungs & Breathing4 studies
  • Heart & Vascular3 studies
  • Diabetes & Metabolism1 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Vancouver, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Vancouver

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Vancouver participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Vancouver pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
How do I join a study in Vancouver, WA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Vancouver?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Vancouver?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Vancouver.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Vancouver typically complete one or two studies per year.

Paid clinical trials near Vancouver

Other metros within reach

Portland, OR1,016 Salem, OR111 Olympia, WA224 Tacoma, WA1,445 Eugene, OR148 Bremerton, WA1,467 Seattle, WA1,492 Bellevue, WA1,500

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Vancouver Bladder Issues Due To Spinal Cord Injury in Vancouver All conditions

More of WA

Bellevue1,500 Seattle1,492 Bremerton1,467 Tacoma1,445 Spokane293 Olympia224 Marysville199 Kennewick54

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts